ArticleJournal of arrhythmia2022
Revised HAS-BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants.
Article in Journal of arrhythmia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Association of Direct Oral Anticoagulant-Proton Pump Inhibitor Co-Therapy with Adverse Outcomes: A Population-Based Cohort Study.The Annals of pharmacotherapy · 2026Article
- Left atrial appendage occlusion needs lifetime management not lifetime medications.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024Article
- Comparative outcomes of catheter-directed thrombolysis versus AngioJet pharmacomechanical catheter-directed thrombolysis for treatment of acute iliofemoral deep vein thrombosis.Journal of vascular surgery. Venous and lymphatic disorders · 2024Article
- Assessing adherence to treatment guidelines and complications among atrial fibrillation patients in the United Arab Emirates.Frontiers in cardiovascular medicine · 2024Article
- Revised HAS-BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants.Journal of arrhythmia · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There were several limitations to the original HAS-BLED (oHAS-BLED) score in patients with atrial fibrillation (AF). This trial studied the revised HAS-BLED (rHAS-BLED) score for predicting bleeding events in anticoagulated AF patients. Methods: This study retrospectively recruited anticoagulated AF patients in the Central Chest Institute of Thailand between 2014 and 2021. The rHAS-BLED score was oHAS-BLED using the estimated glomerular filtration rate of <60 ml/min/1.73 m Results: A total of 256 anticoagulated AF patients were enrolled. The average age was 73.6 ± 10.1 years. The average oHAS-BLED and rHAS-BLED scores were 1.7 ± 0.9 and 2.6 ± 1.2, respectively. Twenty patients in rHAS-BLED ≥3 (15.9%) and 9 patients in rHAS-BLED <3 (6.9%) experienced MB and/or CRNMB. The rHAS-BLED score of ≥3 increased the bleeding risk with statistical significance (OR 2.54, 95% CI 1.11-5.81, Conclusions: The rHAS-BLED score could predict bleeding events in anticoagulated AF patients. However, a larger study is needed to confirm these results in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.